Enrolling patients in a clinical trial necessitates the provision of comprehensive information regarding the study, its associated risks and benefits, and the expectations tied to participation. The decision to provide informed consent is crucial, and its effectiveness depends on tailoring the approach to the unique characteristics of both the trial and the patient population.
For intricate trials, particularly those in oncology or rare diseases, and especially with "trial naïve" patients facing a new diagnosis, the eConsent process can be overwhelming. In such cases, adopting a more patient-centric approach, incorporating multimedia elements, and creating interactive documents can significantly enhance the patient experience, promoting better comprehension of the study.
Conversely, in studies such as phase 4 or observational research, where the information conveyed involves limited risk, and patient education takes a backseat to document tracking, a simpler approach suffices. In this webinar, IQVIA eConsent expert Karen Maduschke delves into the art of tailoring the eConsent experience to match the specific needs of your study and patients.
In addition, the speaker also covers considerations for planning an effective eConsent strategy, tools and features to seek in an eConsent platform, and approaches that align with different types of trials. Gain valuable insights and examples drawn from Karen's extensive decade-long experience in this domain by watching the full presentation below.